Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Avish Arora; Roman Deniskin; Yvett Sosa; Sita Nirupama Nishtala; Philipp P. Henrich; T.R. Santha Kumar; David A. Fidock; Myles H. Akabas

doi:10.1124/mol.115.101386

Research ArticleArticle

Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Avish Arora, Roman Deniskin, Yvett Sosa, Sita Nirupama Nishtala, Philipp P. Henrich, T.R. Santha Kumar, David A. Fidock and Myles H. Akabas

Molecular Pharmacology April 5, 2016, mol.115.101386; DOI: https://doi.org/10.1124/mol.115.101386

Avish Arora

1 Albert Einstein College of Medicine;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roman Deniskin

1 Albert Einstein College of Medicine;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yvett Sosa

1 Albert Einstein College of Medicine;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sita Nirupama Nishtala

1 Albert Einstein College of Medicine;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philipp P. Henrich

2 Columbia University College of Physicians and Surgeons;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

T.R. Santha Kumar

2 Columbia University College of Physicians and Surgeons;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David A. Fidock

3 Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Myles H. Akabas

1 Albert Einstein College of Medicine;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

In this issue

Molecular Pharmacology

Vol. 101, Issue 2

1 Feb 2022

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleArticle

Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Avish Arora, Roman Deniskin, Yvett Sosa, Sita Nirupama Nishtala, Philipp P. Henrich, T.R. Santha Kumar, David A. Fidock and Myles H. Akabas

Molecular Pharmacology April 5, 2016, mol.115.101386; DOI: https://doi.org/10.1124/mol.115.101386

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleArticle

Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Avish Arora, Roman Deniskin, Yvett Sosa, Sita Nirupama Nishtala, Philipp P. Henrich, T.R. Santha Kumar, David A. Fidock and Myles H. Akabas

Molecular Pharmacology April 5, 2016, mol.115.101386; DOI: https://doi.org/10.1124/mol.115.101386

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Main menu

User menu

Search

Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Plain text

Vertical Tabs

Jump to comment:

In this issue

Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Citation Manager Formats

Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1)

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals